BeiGene Statistics
Total Valuation
BeiGene has a market cap or net worth of 18.75 billion. The enterprise value is 17.09 billion.
| Market Cap | 18.75B |
| Enterprise Value | 17.09B |
Important Dates
The next estimated earnings date is Tuesday, February 25, 2025.
| Earnings Date | Feb 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -0.07% |
| Shares Change (QoQ) | +0.26% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 63.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | 5.64 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -20.00 |
| EV / Sales | 5.10 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -14.34 |
Financial Position
The company has a current ratio of 1.94, with a Debt / Equity ratio of 0.31.
| Current Ratio | 1.94 |
| Quick Ratio | 1.64 |
| Debt / Equity | 0.31 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.88 |
| Interest Coverage | -57.74 |
Financial Efficiency
Return on equity (ROE) is -23.22% and return on invested capital (ROIC) is -12.29%.
| Return on Equity (ROE) | -23.22% |
| Return on Assets (ROA) | -9.58% |
| Return on Capital (ROIC) | -12.29% |
| Revenue Per Employee | 316,161 |
| Profits Per Employee | -80,606 |
| Employee Count | 10,600 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 1.44 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +0.77% in the last 52 weeks. The beta is 0.62, so BeiGene's price volatility has been lower than the market average.
| Beta (5Y) | 0.62 |
| 52-Week Price Change | +0.77% |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 40.95 |
| Average Volume (20 Days) | 641 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.43 |
Income Statement
In the last 12 months, BeiGene had revenue of 3.35 billion and -854.42 million in losses. Loss per share was -8.19.
| Revenue | 3.35B |
| Gross Profit | 2.80B |
| Operating Income | -886.48M |
| Pretax Income | -801.31M |
| Net Income | -854.42M |
| EBITDA | -794.98M |
| EBIT | -886.48M |
| Loss Per Share | -8.19 |
Balance Sheet
The company has 2.71 billion in cash and 1.05 billion in debt, giving a net cash position of 1.66 billion.
| Cash & Cash Equivalents | 2.71B |
| Total Debt | 1.05B |
| Net Cash | 1.66B |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 3.45B |
| Book Value Per Share | 32.32 |
| Working Capital | 1.89B |
Cash Flow
In the last 12 months, operating cash flow was -649.87 million and capital expenditures -541.71 million, giving a free cash flow of -1.19 billion.
| Operating Cash Flow | -649.87M |
| Capital Expenditures | -541.71M |
| Free Cash Flow | -1.19B |
| FCF Per Share | n/a |
Margins
Gross margin is 83.67%, with operating and profit margins of -26.45% and -25.50%.
| Gross Margin | 83.67% |
| Operating Margin | -26.45% |
| Pretax Margin | -23.91% |
| Profit Margin | -25.50% |
| EBITDA Margin | -23.72% |
| EBIT Margin | -26.45% |
| FCF Margin | n/a |
Dividends & Yields
BeiGene does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 0.07% |
| Shareholder Yield | 0.07% |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BeiGene has an Altman Z-Score of 2.96. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.96 |
| Piotroski F-Score | n/a |